How New Treatment Options for Amyloidosis Changed Giselle’s Life

When patient advocate Giselle Benmoin was diagnosed with hereditary ATTR amyloidosis, a rare, progressive disease that can affect the heart, treatment meant a four-hour infusion. Today, thanks to medical innovation, it takes a fifteen-minute doctor’s visit. “I’m able to get more of my life back,” she says. Now she’s working to raise awareness of amyloidosis, help people understand their risk and encourage early genetic testing. Learn more about her journey with hATTR.